| Novartis Pharma Schweiz AG - Kisqali 200 mg, Filmtabletten | | 66377 | | 01 | | Kisqali 200 mg | | Filmtabletten | | L01EF02 | | Ribociclib | | 24.10.2017 | | |
| | Composition | | ribociclibum 200 mg ut ribociclibi succinas 254.40 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, crospovidonum, magnesii stearas, silica colloidalis anhydrica, Überzug: poly(alcohol vinylicus), talcum, lecithinum, xanthani gummi, E 171, E 172, pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Ribociclibum | 200 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Ribociclibum | 200 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| Cellulosum Microcristallinum | | | | Crospovidonum | | | | E 171 | | color. | | E 172 | | color. | | Hydroxypropylcellulosum Substitutum Humile | | | | Lecithine | | | | Magnesii Stearas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | | | Xanthani Gummi | | |
| |
| |
|
